Lorraine Mooney

1.2k total citations · 1 hit paper
23 papers, 918 citations indexed

About

Lorraine Mooney is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Lorraine Mooney has authored 23 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Economics and Econometrics. Recurrent topics in Lorraine Mooney's work include Pharmaceutical Economics and Policy (10 papers), Pharmaceutical Quality and Counterfeiting (10 papers) and Fibroblast Growth Factor Research (4 papers). Lorraine Mooney is often cited by papers focused on Pharmaceutical Economics and Policy (10 papers), Pharmaceutical Quality and Counterfeiting (10 papers) and Fibroblast Growth Factor Research (4 papers). Lorraine Mooney collaborates with scholars based in United Kingdom, United States and Canada. Lorraine Mooney's co-authors include Elaine Kilgour, Dawn Baker, Paul R. Gavine, Tanya Coleman, Claire Rooney, Andrew P. Thomas, Teresa Klinowska, Katherine Al-Kadhimi, Sarah Beck and Martine J. Mellor and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Lorraine Mooney

22 papers receiving 884 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

2012 415 citations Paul R. Gavine, Lorraine Mooney et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorraine Mooney United Kingdom	11	589	193	169	131	101	23	918
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani Netherlands	15	1.2k 2.1×	200 1.0×	244 1.4×	126 1.0×	295 2.9×	33	2.1k
Lars Beckmann Germany	16	343 0.6×	156 0.8×	132 0.8×	136 1.0×	36 0.4×	36	898
Dineo Khabele United States	22	847 1.4×	450 2.3×	168 1.0×	115 0.9×	54 0.5×	54	1.6k
Xiaoming Zou China	13	370 0.6×	155 0.8×	114 0.7×	241 1.8×	20 0.2×	25	825
Qing Zhou China	19	350 0.6×	487 2.5×	150 0.9×	241 1.8×	51 0.5×	62	1.1k
Shalini Verma United States	11	553 0.9×	227 1.2×	96 0.6×	251 1.9×	77 0.8×	15	1.2k
Christopher Twelves United Kingdom	18	467 0.8×	630 3.3×	205 1.2×	139 1.1×	34 0.3×	53	1.3k
Tsion Z. Minas United States	16	310 0.5×	200 1.0×	125 0.7×	58 0.4×	32 0.3×	27	645
Linda S. Wood United States	20	392 0.7×	283 1.5×	152 0.9×	57 0.4×	46 0.5×	45	1.2k
Kasper Langebjerg Andersen Denmark	10	418 0.7×	283 1.5×	295 1.7×	53 0.4×	96 1.0×	17	938

Countries citing papers authored by Lorraine Mooney

Since Specialization

Citations

This map shows the geographic impact of Lorraine Mooney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Mooney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Mooney more than expected).

Fields of papers citing papers by Lorraine Mooney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Mooney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Mooney. The network helps show where Lorraine Mooney may publish in the future.

Co-authorship network of co-authors of Lorraine Mooney

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Mooney. A scholar is included among the top collaborators of Lorraine Mooney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Mooney. Lorraine Mooney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karp, Natasha A., et al.. (2020). A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study. Scientific Reports. 10(1). 6178–6178. 22 indexed citations

Bethell, Richard C., Cath Eberlein, Victoria W. Pollard, et al.. (2020). Abstract 2887: Bispecific antibody drug conjugates targeting CD7 and CD33 for the treatment of acute myeloid leukemia. Cancer Research. 80(16_Supplement). 2887–2887. 2 indexed citations

Taylor, Molly A., Adina Hughes, Josephine Walton, et al.. (2019). Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery. Journal for ImmunoTherapy of Cancer. 7(1). 328–328. 70 indexed citations

Carnevalli, Larissa S., Charles Sinclair, Molly A. Taylor, et al.. (2018). PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. Journal for ImmunoTherapy of Cancer. 6(1). 158–158. 71 indexed citations

Delpuech, Oona, Claire Rooney, Lorraine Mooney, et al.. (2016). Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547. Molecular Cancer Therapeutics. 15(11). 2802–2813. 18 indexed citations

Bate, Roger, et al.. (2013). Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. The International Journal of Tuberculosis and Lung Disease. 17(3). 308–311. 3 indexed citations

Gavine, Paul R., Lorraine Mooney, Elaine Kilgour, et al.. (2012). AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family. Cancer Research. 72(8). 2045–2056. 415 indexed citations breakdown →

Bate, Roger, et al.. (2012). Anti-infective medicine quality: analysis of basic product quality by approval status and country of manufacture. PubMed. 3. 57–57. 2 indexed citations

Bate, Roger, et al.. (2012). Subsidizing artemisinin-based combination therapies: a preliminary investigation of the Affordable Medicines Facility - malaria.. PubMed. 3. 63–68.

10.

Thomas, Andrew P., Maria‐Elena Theoclitou, David Buttar, et al.. (2012). Abstract 3912: The discovery of AZD4547: An orally bioavailable, potent and selective N-(5-Pyrazolyl)benzamide FGFR1-3 inhibitor. Cancer Research. 72(8_Supplement). 3912–3912. 1 indexed citations

11.

Critchlow, Susan E., Lorraine Mooney, Nicola J. Curtis, et al.. (2012). Abstract 3224: Pre-clinical targeting of the metabolic phenotype of lymphoma by AZD3965, a selective inhibitor of monocarboxylate transporter 1 (MCT1). Cancer Research. 72(8_Supplement). 3224–3224. 11 indexed citations

12.

Gavine, Paul R., Lorraine Mooney, Elaine Kilgour, et al.. (2011). Abstract 3568: Characterization of AZD4547: An orally bioavailable, potent and selective inhibitor of FGFR tyrosine kinases 1, 2 and 3. Cancer Research. 71(8_Supplement). 3568–3568. 11 indexed citations

13.

Bate, Roger, et al.. (2011). The Danger of Substandard Drugs in Emerging Markets: An Assessment of Basic Product Quality. Pharmacologia. 3(2). 46–51. 1 indexed citations

14.

Bate, Roger, et al.. (2011). Dangerous Substandard Medicines: An Increasing Global Problem. SSRN Electronic Journal. 2 indexed citations

15.

Bate, Roger, Lorraine Mooney, & Kimberly Hess. (2010). Medicine Registration and Medicine Quality: A Preliminary Analysis of Key Cities in Emerging Markets. SSRN Electronic Journal. 6 indexed citations

16.

Bate, Roger, Kimberly Hess, & Lorraine Mooney. (2010). Antimalarial Medicine Diversion: Stock-Outs and Other Public Health Problems. SHILAP Revista de lepidopterología. 6 indexed citations

17.

Bate, Roger, et al.. (2009). Pilot Study of Essential Drug Quality in Two Major Cities in India. SSRN Electronic Journal. 6 indexed citations

18.

Bate, Roger, et al.. (2009). Pilot study comparing technologies to test for substandard drugs in field settings. SSRN Electronic Journal. 35 indexed citations

19.

Bate, Roger, et al.. (2009). Pilot Study of Essential Drug Quality in Two Major Cities in India. PLoS ONE. 4(6). e6003–e6003. 62 indexed citations

20.

Roche, S., Chunping Zhao, E. Claffey, et al.. (2007). Candidate gene analysis of 21q22: Support for S100B as a susceptibility gene for bipolar affective disorder with psychosis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 144B(8). 1094–1096. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact